Cargando…
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence
SIMPLE SUMMARY: Hodgkin lymphoma (HL) is a highly curable disease; in this context, the limitation of late adverse events is of prime importance for the patient. Proton therapy for mediastinal HL irradiation theoretically limits secondary cancer excess risk and should reduce late toxicities compared...
Autores principales: | Loap, Pierre, Mirandola, Alfredo, De Marzi, Ludovic, Dendale, Remi, Iannalfi, Alberto, Vitolo, Viviana, Barcellini, Amelia, Filippi, Andrea Riccardo, Jereczek-Fossa, Barbara Alicja, Kirova, Youlia, Orlandi, Ester |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345146/ https://www.ncbi.nlm.nih.gov/pubmed/34359647 http://dx.doi.org/10.3390/cancers13153746 |
Ejemplares similares
-
Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives
por: Loap, Pierre, et al.
Publicado: (2021) -
Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice
por: Loap, Pierre, et al.
Publicado: (2021) -
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review
por: Loap, Pierre, et al.
Publicado: (2021) -
PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
por: Barcellini, Amelia, et al.
Publicado: (2021) -
Fast Neutron Therapy for Breast Cancer Treatment: An Effective Technique Sinking into Oblivion
por: Loap, Pierre, et al.
Publicado: (2020)